“Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s127. doi:10.25251/skin.1.supp.126.